04.06.2021
EMA Expresses No Significant Concerns About Sputnik V Production or Clinical Trials, RDIF Says
ST. PETERSBURG (Sputnik) - The European Medicines Agency (EMA), which is currently studying Russia's Sputnik V vaccine against COVID-19...
01.06.2021
Russian Ambassador: SputnikV efficacy at 91.8% in elderly, EU to examine vaccine this month
The first Russian vaccine against COVID-19, SputnikV, named after the first artificial space satellite in history, has been approved so far in 23 countries...
01.05.2021
Sputnik V vaccine has 91.6% efficacy against symptomatic Covid, Russian trial suggests
The Sputnik V vaccine, which has been the subject of scepticism since Russia began using it last year before trials had ended, is 91.6% effective..